Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Sun Pharmaceutical Industries Limited is a pharmaceuticals company which offers generics, branded generics, specialty products, over-the-counter products, anti-retroviral and APIs.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
10 hours ago•Business Today
16 hours ago•Business Standard
16 hours ago•Bloomberg Quint
Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Further to our intimation filed on 2nd March 2023, regarding an Information Technology ( IT ) security incident, we wish to provide an update.'. | Download
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Further to our intimation filed on 2nd March 2023, regarding an Information Technology ( IT ) security incident, we wish to provide an update.'. | Download
Interim • Div/Share: ₹ 7.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant